Health Canada approves Pfizer's new COVID-19 vaccine targeting Omicron XBB.1.5 subvariant
Health Canada has given its stamp of approval to the use of Pfizer-BioNTech Comirnaty's new COVID-19 vaccine that targets the Omicron XBB.1.5 subvariant.
Health Canada has given its stamp of approval to the use of Pfizer-BioNTech Comirnaty's new COVID-19 vaccine that targets the Omicron XBB.1.5 subvariant.